Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma.
Gunda V, Pathania AS, Chava S, Prathipati P, Chaturvedi NK, Coulter DW, Pandey MK, Durden DL, Challagundla KB. Gunda V, et al. Among authors: prathipati p. Cancers (Basel). 2020 Sep 10;12(9):2576. doi: 10.3390/cancers12092576. Cancers (Basel). 2020. PMID: 32927667 Free PMC article.
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges.
Pathania AS, Prathipati P, Abdul BA, Chava S, Katta SS, Gupta SC, Gangula PR, Pandey MK, Durden DL, Byrareddy SN, Challagundla KB. Pathania AS, et al. Among authors: prathipati p. Theranostics. 2021 Jan 1;11(2):731-753. doi: 10.7150/thno.51471. eCollection 2021. Theranostics. 2021. PMID: 33391502 Free PMC article. Review.
miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma.
Pathania AS, Prathipati P, Olwenyi OA, Chava S, Smith OV, Gupta SC, Chaturvedi NK, Byrareddy SN, Coulter DW, Challagundla KB. Pathania AS, et al. Among authors: prathipati p. Mol Ther Oncolytics. 2022 Mar 31;25:308-329. doi: 10.1016/j.omto.2022.03.010. eCollection 2022 Jun 16. Mol Ther Oncolytics. 2022. PMID: 35663229 Free PMC article.
Immune checkpoint molecules in neuroblastoma: A clinical perspective.
Pathania AS, Prathipati P, Murakonda SP, Murakonda AB, Srivastava A, Avadhesh, Byrareddy SN, Coulter DW, Gupta SC, Challagundla KB. Pathania AS, et al. Among authors: prathipati p. Semin Cancer Biol. 2022 Nov;86(Pt 2):247-258. doi: 10.1016/j.semcancer.2022.06.013. Epub 2022 Jul 3. Semin Cancer Biol. 2022. PMID: 35787940 Review.
Exploring the epigenetic drug discovery landscape.
Prachayasittikul V, Prathipati P, Pratiwi R, Phanus-Umporn C, Malik AA, Schaduangrat N, Seenprachawong K, Wongchitrat P, Supokawej A, Prachayasittikul V, Wikberg JE, Nantasenamat C. Prachayasittikul V, et al. Among authors: prathipati p. Expert Opin Drug Discov. 2017 Apr;12(4):345-362. doi: 10.1080/17460441.2017.1295954. Epub 2017 Feb 28. Expert Opin Drug Discov. 2017. PMID: 28276705 Review.
Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling.
Shoombuatong W, Prathipati P, Prachayasittikul V, Schaduangrat N, Malik AA, Pratiwi R, Wanwimolruk S, Wikberg JES, Gleeson MP, Spjuth O, Nantasenamat C. Shoombuatong W, et al. Among authors: prathipati p. Curr Drug Metab. 2017 Jul 21;18(6):540-555. doi: 10.2174/1389200218666170320121932. Curr Drug Metab. 2017. PMID: 28322159 Review.
60 results